Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers
Collaboration will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global… Read More




